Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies
Yue Zhao, Qiongzhu Dong, Jiahui Li, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 139-155
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah, Metka Novak, Barbara Breznik
Seminars in Cancer Biology (2019) Vol. 60, pp. 262-273
Open Access | Times Cited: 325
Drug resistance and Cancer stem cells
Yuan Li, Zhenning Wang, Jaffer A. Ajani, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 232
Recent advances in drug delivery systems for targeting cancer stem cells
Hongxia Duan, Yanhong Liu, Zhonggao Gao, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 55-70
Open Access | Times Cited: 198
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 181
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 177
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
Julia López de Andrés, Carmen Griñán‐Lisón, Gema Jiménez, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 162
The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities
Michael S. Yu, Kevin Qin, Jiaming Fan, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 101026-101026
Open Access | Times Cited: 43
Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells
Huangcan Li, Zhuoying Feng, Ming‐Liang He
Theranostics (2020) Vol. 10, Iss. 16, pp. 7053-7069
Open Access | Times Cited: 118
Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
Lisha Ai, Shidai Mu, Chunyan Sun, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 116
Hyaluronan-CD44 axis orchestrates cancer stem cell functions
Spyros S. Skandalis, Theodoros Karalis, Athanasios Chatzopoulos, et al.
Cellular Signalling (2019) Vol. 63, pp. 109377-109377
Closed Access | Times Cited: 111
VEGF/Neuropilin Signaling in Cancer Stem Cells
Arthur M. Mercurio
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 490-490
Open Access | Times Cited: 93
The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials
Céline Hervieu, Niki Christou, Serge Battu, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 73
Cancer Stemness: p53 at the Wheel
Dishari Ghatak, Damayanti Das Ghosh, Susanta Roychoudhury
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 61
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
Poornima Verma, Neha Shukla, Shivani Kumari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188887-188887
Closed Access | Times Cited: 36
The Significance of Cancer Stem Cells and Epithelial–Mesenchymal Transition in Metastasis and Anti-Cancer Therapy
Lili Liang, Andreas M. Kaufmann
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2555-2555
Open Access | Times Cited: 33
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 24
Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
Puja Sandbhor, Pranoti Palkar, Sakshi Bhat, et al.
Nanoscale (2024) Vol. 16, Iss. 13, pp. 6330-6364
Closed Access | Times Cited: 14
Pterostilbene in the treatment of inflammatory and oncological diseases
Peijun Liu, Weihua Tang, Kali Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 13
MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma
Hongyu Xu, Zedong Du, Zhihui Li, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis
Zhishan Wang, Chengfeng Yang
Seminars in Cancer Biology (2019) Vol. 57, pp. 95-104
Open Access | Times Cited: 67
Molecular landscape of recurrent cervical cancer
Divya Adiga, Sangavi Eswaran, Deeksha Pandey, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103178-103178
Closed Access | Times Cited: 67
Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment
Bernarda Majc, Tilen Sever, Miki Zarić, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 10, pp. 118782-118782
Open Access | Times Cited: 66
Breast cancer stem cell antigens as targets for immunotherapy
Elena Quaglino, Laura Conti, Federica Cavallo
Seminars in Immunology (2020) Vol. 47, pp. 101386-101386
Open Access | Times Cited: 65
Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms
Mariusz Z. Ratajczak, Kamila Bujko, Aaron Mack, et al.
Leukemia (2018) Vol. 32, Iss. 12, pp. 2519-2526
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top